FIFAX Abp
Fifax is an Åland-based aquaculture company focused on land-based fish farming using recirculating aquaculture system (RAS) technology. Its business centers on producing farmed fish in a controlled environment and handling the related processing, with operations anchored in Eckerö, Finland.
Fiscal year 2024 · change from previous year
Development 2020–2024
Business
Share of revenueProduction of fish in a controlled land-based RAS environment.
Value-added fish products prepared for consumer and trade channels.
Head-on-gutted whole fish sold to downstream processors and distributors.
Customers
Fifax sells into the food value chain, where buyers include processors, distributors, and HoReCa customers that use the fish as an input to their own offerings. The company also targets end-consumer demand indirectly through branded and further-processed products, especially in the Baltic Sea region where sustainably produced local fish is a selling point.
Buy HOG fish for filleting, packaging, and onward distribution.
Buy fish for restaurant and catering menus that value local supply.
Buy processed fish products and branded offerings for end consumers.
Strategy
Fifax's strategy is built around sustainable large-scale fish farming with RAS technology, which reduces water use and captures production side streams. The company aims to move further up the value chain by processing fish into consumer products and strengthening its own brand and market awareness.
Higher output and controlled conditions support the core aquaculture model.
Processing fish into consumer products can improve pricing power and market reach.
Environmental performance is central to customer demand and differentiation.
Geography
The company is headquartered and operates in Eckerö, Åland, with its production site tied to the Finnish market. Its commercial focus is the Baltic Sea region, where demand for local and environmentally responsible seafood is a key part of the value proposition.
Risks
The business depends on biological production performance, so fish health, mortality, feed conversion, and water quality can materially affect output. It also faces execution risk in ramping production and in converting a capital-intensive RAS facility into a stable commercial platform, while demand and pricing remain tied to seafood market conditions and regional supply chains.
- Fish health and mortalityImpact: HighLikelihood: High
Aquaculture output depends on biological performance and disease control.
Exposure: Production volumes and product quality
- Operational ramp-up riskImpact: HighLikelihood: Medium
A RAS facility requires stable 24/7 control of water, stock, and process conditions.
Exposure: Facility utilization and commercial continuity
- Market demand and pricingImpact: MediumLikelihood: Medium
Revenue depends on seafood demand and the prices buyers are willing to pay.
Exposure: Sales volumes and realized prices
- Energy and input cost exposureImpact: MediumLikelihood: Medium
Land-based aquaculture uses significant power, feed, and operating inputs.
Exposure: Operating economics
Accounting
Judgemental itemsInterest incurred during construction was capitalized into buildings and is depreciated over time.
Impact: Affects asset values and future depreciation expense
Received investment support can become repayable if operations change materially or cease within the defined period.
Impact: Creates contingent liability and disclosure sensitivity
Production facilities involve lease-related deposits and likely lease commitments.
Impact: Affects balance sheet liabilities and operating expense timing
Similar listed companies
Publicly listed companies with a comparable business focus.
Healthier Choices Management Corp.
HCMC · Tobacco Products
Hong Yuan Holding Group
HGYN · Plastic Materials, Synth Resins & Nonvulcan Elastomers
HONG YUAN HOLDING GROUP is a U.S.-listed company in the plastics and synthetic resins value chain.
Valuence Merger Corp. I
VMCUF · Blank Checks
Valuence Merger Corp.
American Exceptionalism Acquisition Corp. A
AEXA · Blank Checks
American Exceptionalism Acquisition Corp.
Artificial Intelligence Technology Solutions Inc.
AITX · Services-Prepackaged Software
Amgen Inc
AMGN · Biological Products, (No Diagnostic Substances)
Last updated: 24/09/2026